藥品參考
Prasugrel
Prasugrel is a medicine in the class cardiovascular. It is used for acute coronary syndrome.
- 藥物類別: Cardiovascular
- 用途: acute coronary syndrome
最後更新 來源: US FDA label
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Cardiovascular
- ATC 代碼
- B01AC22
- 常見劑型
- 錠劑
- 已知交互作用
- 51 (嚴重: 34 · 中度: 15 · 輕微: 2)
- 商品名
- 3
- 國家與市場
- 2
用途
作用方式
Prasugrel's active metabolite binds irreversibly to the P2Y12 class of ADP receptors on platelets, inhibiting platelet activation and aggregation.
成人常用劑量（仿單摘要）
Acute coronary syndrome managed with PCI: 60 mg oral loading dose, then 10 mg orally once daily, with or without food; take with aspirin 75 mg to 325 mg daily
懷孕與哺乳
- 懷孕
- Unknown No human data. No structural malformations in animals. Consider benefits and risks to the fetus given the bleeding risk.
- 哺乳
- Unknown No information on presence in human milk; metabolites found in rat milk. Weigh benefits of breastfeeding against maternal need.
已通報的副作用
- Bleeding (including life-threatening and fatal)
- Epistaxis
- Gastrointestinal hemorrhage
- Hemoptysis
- Subcutaneous hematoma
- Post-procedural hemorrhage
黑框警語
- Effient can cause significant, sometimes fatal, bleeding. Do not use in patients with active pathological bleeding or a history of TIA or stroke. In patients ≥75 years it is generally not recommended, except in high-risk patients (diabetes or prior MI). Do not start in patients likely to undergo urgent CABG; when possible discontinue at least 7 days before any surgery. Other bleeding risk factors: body weight <60 kg, propensity to bleed, and concomitant medications that increase bleeding risk. Suspect bleeding in hypotensive patients after invasive or surgical procedures. If possible, manage…
禁忌症
- Active pathological bleeding such as peptic ulcer or intracranial hemorrhage
- History of prior transient ischemic attack or stroke
- Hypersensitivity (e.g., anaphylaxis) to prasugrel or any component of the product
哪些人需要特別留意
- Thienopyridines increase bleeding risk, which is highest initially; suspect bleeding in hypotensive patients after procedures
- CABG-related bleeding risk is increased; discontinue at least 7 days before CABG if possible
- Premature discontinuation increases risk of stent thrombosis, MI and death; avoid lapses in therapy
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (51)
- Acetylsalicylic acid + Prasugrel Major
- Apixaban + Prasugrel Major
- Argatroban + Prasugrel Major
- Cangrelor + Prasugrel Major
- Celecoxib + Prasugrel Major
- Dabigatran etexilate + Prasugrel Major
- Dalteparin + Prasugrel Major
- Deferasirox + Prasugrel Major
- Diclofenac + Prasugrel Major
- Diflunisal + Prasugrel Major
Pro+ 會員專屬
解鎖完整頁面
建立帳號並開始 Pro+ 試用，即可開啟 Prasugrel 的完整藥品專論：劑量、懷孕與哺乳、副作用、警示及所有交互作用。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
在網頁版免費試用 Pro+ 14 天，無需信用卡。
同類別的其他藥品
常見問題
What is Prasugrel used for?
Prasugrel is a medicine in the class cardiovascular. It is used for Acute coronary syndrome.
What side effects have been reported with Prasugrel?
Bleeding (including life-threatening and fatal), Epistaxis, Gastrointestinal hemorrhage, Hemoptysis, Subcutaneous hematoma, Post-procedural hemorrhage. Serious warning: Effient can cause significant, sometimes fatal, bleeding.
Can Prasugrel be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No human data. No structural malformations in animals. Consider benefits and risks to the fetus given the bleeding risk. Breastfeeding: Unknown. No information on presence in human milk; metabolites found in rat milk. Weigh benefits of breastfeeding against maternal need.
What does Prasugrel interact with?
MediHelp lists 51 known interactions for Prasugrel. Major: 34 · Moderate: 15 · Minor: 2. The most serious include Acetylsalicylic acid, Apixaban, Argatroban.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
